Header image

Session G: HCV Diagnosis and Linkage to Care

Thursday, September 7, 2017
9:00 AM - 11:10 AM
Manhattan Ballroom

Speaker

Attendee912

Novel Diagnostics for HCV Infection: Where are we Now and Where are we Headed?

9:00 AM - 9:25 AM

Speaker Presentation

Video Presentation

Biography

Attendee550

Novel Strategies to Enhance Testing and Linkage to HCV Care and Treatment

9:25 AM - 9:50 AM

Speaker Presentation

Video Presentation

Biography

Attendee320

How to Work with People who Inject Drugs in Building Relevant Models of HCV Care?

9:50 AM - 10:15 AM

Speaker Presentation

Video Presentation

Biography

Attendee537

Identity Transformations and other Unexpected Benefits of HCV Treatment: A Review of the Evidence and Reflections for the DAA Era

10:15 AM - 10:40 AM

Speaker Presentation

Video Presentation

Biography

Attendee309

Efficacy and Safety of Sofosbuvir/ Velpatasvir in People with Chronic HCV Infection and Recent Injecting Drug Use: The SIMPLIFY Study

10:40 AM - 10:55 AM

Abstract

Speaker Presentation

Biography

Attendee406

Randomized Controlled Trial of Cash Incentives or Peer Mentors to Improve HCV Linkage and Treatment among HIV/HCV Coinfected Persons who Inject Drugs: the Champs Study

10:55 AM - 11:10 AM

Abstract

Speaker Presentation

Biography

loading